Historical record - last NADAC publication: 11/23/2016
Product Information
PERPHEN-AMITRIP 4 MG-25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.6423 per EA under NDC 00378057401. Its NADAC has been published 212 times since Nov 28, 2013.
Strength
25; 4 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378057401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
11/23/2016
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINEApproval Type
Generic (ANDA)
FDA Application
ANDA071443On Market Since
11/10/1988
Pharmacological Classes
Price Statistics
The NADAC for PERPHEN-AMITRIP 4 MG-25 MG TAB has been published 212 times since Nov 28, 2013, and over the history we have for it it has risen 107.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6423 per EA |
|---|---|
| All-time high | $1.6863 (Nov 16, 2016) |
| All-time low | $0.7647 (Dec 18, 2013) |
| Median price | $1.3940 |
| Average price | $1.3483 |
| Largest weekly change | +24.4% (Jun 18, 2014) |
| Weeks tracked | 212 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the perphenazine and amitriptyline hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PERPHEN-AMITRIP 4 MG-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PERPHEN-AMITRIP 4 MG-25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $1.6423 per EA (NDC 00378057401), effective Dec 13, 2017.
How has the price of PERPHEN-AMITRIP 4 MG-25 MG TAB changed over time?
Over the history we have for it, the NADAC for PERPHEN-AMITRIP 4 MG-25 MG TAB has risen 107.3%. It has been tracked across 212 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PERPHEN-AMITRIP 4 MG-25 MG TAB?
Since Nov 28, 2013, the NADAC for PERPHEN-AMITRIP 4 MG-25 MG TAB has ranged from a low of $0.7647 (Dec 18, 2013) to a high of $1.6863 (Nov 16, 2016), with a median of $1.3940 per EA.
Are there cheaper alternatives to PERPHEN-AMITRIP 4 MG-25 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PERPHEN-AMITRIP 4 MG-25 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures PERPHEN-AMITRIP 4 MG-25 MG TAB?
PERPHEN-AMITRIP 4 MG-25 MG TAB (NDC 00378057401) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification